Showing results (61-70 of 357) with videos related to
Sort By:
Pageof 36
Pharmacology, Biochemistry, and Behavior|April 1, 1997
Towards a cannabinoid hypothesis of schizophrenia: cognitive impairments due to dysregulation of the endogenous cannabinoid systemH M Emrich, F M Leweke, U SchneiderFortschritte Der Neurologie-Psychiatrie|May 13, 2003
[Oxcarbazepine in the treatment of affective and schizoaffective disorders]D E Dietrich, S Kropp, H M EmrichArchiv Fur Psychiatrie Und Nervenkrankheiten|January 1, 1979
[Vegetative functions and motor activity in endogenous depression. Longitudinal study on salivary secretion, temperature, and motor activity in a patient with 48-hour cycles (author's transl)]H M Emrich, R Lund, D von ZerssenJournal of Affective Disorders|May 1, 1985
The use of sodium valproate, carbamazepine and oxcarbazepine in patients with affective disordersH M Emrich, M Dose, D von ZerssenDer Nervenarzt|June 2, 2001
[Successful treatment of simple schizophrenia with atypical neuroleptics (clozapine, risperidol)]J D Rollnik, U Schneider, H M EmrichPharmacopsychiatry|January 5, 2002
Oxcarbazepine in affective and schizoaffective disordersD E Dietrich, S Kropp, H M EmrichMolecular Psychiatry|October 11, 2007
The myelin-pathogenesis puzzle in schizophrenia: a literature reviewG Karoutzou, H M Emrich, D E DietrichNeuropharmacology|March 1, 1990
Attenuation of opioid induced antinociception by 5-HT1A partial agonists in the ratM J Millan, F C ColpaertBrain Research|January 25, 1991
Alpha 2 receptors mediate the antinociceptive action of 8-OH-DPAT in the hot-plate test in miceM J Millan, F C ColpaertBritish Journal of Pharmacology|April 1, 1991
Inability of an opioid antagonist lacking negative intrinsic activity to induce opioid receptor up-regulation in vivoB J Morris, M J MillanPageof 36